Modulation of Immunological, Biochemical, and Histopathological Changes of Airway Remodeling by Withania somnifera in an Experimental Model of Allergic Asthma in Rats
Journal of Pharmacopuncture · 30.06.2023 · 26 (2) · 158-166
DOI: 10.3831/kpi.2023.26.2.158 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Pharmacopuncture, erschienen am 30.06.2023. Verfasst von Nafaa Hasan Ali und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, Hamdard Institute of Medical Sciences and Research (HIMSR), Jamia Hamdard University, New Delhi, India. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Indian Council of Medical Research.
Abstract (Originalsprache)
Objectives
Airway remodeling in asthma involves chronic inflammation associated with structural changes, which result in severe airflow limitation and very few therapeutic options. Thus, the present study was designed to experimentally evaluate the ameliorative effects of Withania somnifera (WS) root extract against Ovalbumin (OVA)-induced airway remodeling in a rat model of asthma.
Methods
Wistar rats were immunized (i.p) and challenged (aerosol) with ovalbumin (OVA), and the effects of WS extract were investigated on the development and progress of airway remodeling by assessing immunological, biochemical, and histological changes in these rats.
Results
OVA-immunization and challenge in rats resulted in significant increases in the levels of IL-13, 8-OhdG, TGF-β, hydroxyproline, and periostin in bronchoalveolar lavage fluid (BALF) and serum/lung homogenate compared to normal control (saline only) rats, and these changes were attenuated after WS extract (200 and 400 mg/kg), as well as dexamethasone (DEX, 1 mg/kg) pretreatments. Further, WS extract attenuated histopathological changes and maintained lung integrity. In herb-drug interactions, sub-threshold doses of WS extract and DEX showed synergistic effects on all parameters studied as compared to either form of monotherapy.
Conclusion
These results indicated that WS exerted significant protective effects against airway remodeling in the experimental model by modulating inflammatory and fibrotic cytokines, and could have the potential for developing a therapeutic alternative/adjunct for the treatment of airway remodeling of bronchial asthma.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pharmacology, Hamdard Institute of Medical Sciences and Research (HIMSR), Jamia Hamdard University, New Delhi, India.
- Department of Pharmacology, Vallabhbhai Patel Chest Institute, University of Delhi, Delhi, India.
ORCID-Profile: Nafaa Hasan Ali, Sana Rehman, Maaz Naqvi, Kavita Gulati, Arunabha Ray
Förderung
- Indian Council of Medical Research
Zitieren
APA
Ali, N. H., Rehman, S., Naqvi, M., Gulati, K., & Ray, A. (2023). Modulation of Immunological, Biochemical, and Histopathological Changes of Airway Remodeling by Withania somnifera in an Experimental Model of Allergic Asthma in Rats. Journal of Pharmacopuncture, 26(2), 158-166. https://doi.org/10.3831/kpi.2023.26.2.158
Vancouver
Ali NH, Rehman S, Naqvi M, Gulati K, Ray A. Modulation of Immunological, Biochemical, and Histopathological Changes of Airway Remodeling by Withania somnifera in an Experimental Model of Allergic Asthma in Rats. Journal of Pharmacopuncture. 2023;26(2):158-166. doi:10.3831/kpi.2023.26.2.158
BibTeX
@article{Ali2023,
author = {Ali, Nafaa Hasan and Rehman, Sana and Naqvi, Maaz and Gulati, Kavita and Ray, Arunabha},
title = {Modulation of Immunological, Biochemical, and Histopathological Changes of Airway Remodeling by Withania somnifera in an Experimental Model of Allergic Asthma in Rats},
journal = {Journal of Pharmacopuncture},
year = {2023},
volume = {26},
number = {2},
pages = {158--166},
doi = {10.3831/kpi.2023.26.2.158}
}
EUVIMED